Target Name: MORC4
NCBI ID: G79710
Review Report on MORC4 Target / Biomarker Content of Review Report on MORC4 Target / Biomarker
MORC4
Other Name(s): zinc finger CW-type domain protein 4 | MORC family CW-type zinc finger protein 4 | MORC family CW-type zinc finger protein 4 (isoform a) | dJ75H8.2 | MORC family CW-type zinc finger 4 | Zinc finger CW-type domain protein 4 | ZCW4 | DJ75H8.2 | zinc finger, CW type with coiled-coil domain 2 | MORC4 variant 1 | zinc finger CW-type coiled-coil domain protein 2 | MORC4_HUMAN | MORC family CW-type zinc finger 4, transcript variant 1 | FLJ11565 | Zinc finger CW-type coiled-coil domain protein 2 | ZCWCC2 | Zinc finger, CW type with coiled-coil domain 2

MORC4: A Potential Drug Target and Biomarker for Diseases

MORC4, also known as zinc finger CW-type domain protein 4, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the CW-type zinc finger gene family, which is characterized by the presence of a zinc finger domain in the protein sequence. MORC4 is a unique protein that has been identified as a potential drug target and may also serve as a biomarker for various diseases.

The zinc finger domain is a type of gene regulatory element that is characterized by the presence of a zinc finger protein in the sequence. This protein functions as a transcription factor, and it is known for its ability to activate or repress gene expression. Finger domain is found in many proteins, including openers, enhancers, silencers, etc. MORC4 has a unique zinc finger domain that is different from other proteins. It is composed of 21 amino acids and has a specific structure that is unique among zinc finger proteins.

MORC4 is a protein that is expressed in various tissues and cells throughout the body. It is highly expressed in the brain, heart, and kidneys, and it is also expressed in other organs such as the liver, pancreas, and skin. MORC4 is also expressed in various cell types, including cancer cells, stem cells, and neural cells. This protein is involved in various cellular processes, including cell growth, differentiation, and inflammation.

One of the unique features of MORC4 is its potential as a drug target. MORC4 has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. MORC4 has also been shown to be involved in the regulation of cellular processes that are important for human health, such as cell survival, angiogenesis, and inflammation.

In addition to its potential as a drug target, MORC4 has also been shown to be a potential biomarker for various diseases. The zinc finger domain is a unique structural feature that is expressed in many proteins, but it is not always expressed in human proteins. MORC4 has a unique zinc finger domain that is expressed in human proteins, and this may make it an attractive biomarker for various diseases.

MORC4 is a protein that has the potential to be a drug target for various diseases. The zinc finger domain is a unique structural feature that is expressed in many proteins, but it is not always expressed in human proteins. MORC4 has a unique zinc finger domain that is expressed in human proteins, and this may make it an attractive biomarker for various diseases. Further research is needed to fully understand the role of MORC4 in disease and to explore its potential as a drug target and biomarker.

Protein Name: MORC Family CW-type Zinc Finger 4

Functions: Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 (PubMed:26933034). The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 (PubMed:26933034)

The "MORC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MORC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MORF4 | MORF4L1 | MORF4L1P1 | MORF4L1P3 | MORF4L1P7 | MORF4L2 | MORF4L2-AS1 | MORN1 | MORN2 | MORN3 | MORN4 | MORN5 | MOS | MOSMO | MOSPD1 | MOSPD2 | MOSPD3 | MOV10 | MOV10L1 | MOXD1 | MOXD2P | MPC1 | MPC2 | MPDU1 | MPDU1-AS1 | MPDZ | MPEG1 | MPG | MPHOSPH10 | MPHOSPH10P1 | MPHOSPH6 | MPHOSPH8 | MPHOSPH9 | MPI | MPIG6B | MPL | MPLKIP | MPND | MPO | MPP1 | MPP2 | MPP3 | MPP4 | MPP7 | MPPE1 | MPPED1 | MPPED2 | MPPED2-AS1 | MPRIP | MPST | MPTX1 | MPV17 | MPV17L | MPV17L2 | MPZ | MPZL1 | MPZL2 | MPZL3 | MR1 | MRAP | MRAP2 | MRAS | MRC1 | MRC2 | MRE11 | MREG | MRFAP1 | MRFAP1L1 | MRGBP | MRGPRD | MRGPRE | MRGPRF | MRGPRF-AS1 | MRGPRG | MRGPRX1 | MRGPRX2 | MRGPRX3 | MRGPRX4 | MRI1 | MRLN | MRM1 | MRM2 | MRM3 | MRNIP | MRO | MROCKI | MROH1 | MROH2A | MROH2B | MROH3P | MROH5 | MROH6 | MROH7 | MROH7-TTC4 | MROH8 | MROH9 | MRPL1 | MRPL10 | MRPL11 | MRPL12